Dominic L. Raco, MD, FRCPC
Disclosures: The commentator has disclosed no conflicts of interest. The form can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-2922.
Raco DL. In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y. Ann Intern Med. 2020;172:JC5. doi: https://doi.org/10.7326/ACPJ202001210-005
Download citation file:
Published: Ann Intern Med. 2020;172(2):JC5.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use